Surrozen Set for Healthcare Investor Meeting
Surrozen, Inc., a biotechnology company focused on severe eye diseases, will be presenting at the H.C. Wainwright 27 Annual Global Investment Conference on Wednesday, September 10, 2025. The presentation, taking place from 8:30 - 9:00 AM Pacific Time/11:30 - 12:00 PM Eastern Time, will provide insights into Surrozen's research and development activities.
Surrozen is developing tissue-specific antibodies for ophthalmology, with a focus on targeted therapeutics that selectively modulate the Wnt pathway. These product candidates are in the discovery and development phase, with the potential to bring significant benefits for treating human disease.
The company's presentation will be represented by Leerink Partners, who will discuss Surrozen's proprietary technologies aimed at harnessing the body's biological repair mechanisms. Interested parties can access the audio webcast for the conference on the Investors section of the Surrozen website (https://investors.surrozen.com/events-presentations/events-calendar). A replay of the webcast will be archived on the Surrozen website (
It is important to note that Surrozen does not guarantee the success or timeline of its clinical trials. Factors such as global economic, political, regulatory, and market conditions may impact Surrozen's success. For more information about Surrozen, visit their website at surrozen.com.
For investor and media inquiries, please email [email protected]. Surrozen's risk factors are detailed in its Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
Surrozen's primary focus is on severe eye diseases, a significant health concern worldwide. The company's innovative approach to developing targeted therapeutics offers hope for those suffering from these debilitating conditions. The presentation at the H.C. Wainwright Global Investment Conference promises to be an exciting opportunity to learn more about Surrozen's groundbreaking work.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Tobacco industry's suggested changes on a legislative modification are disregarded by health journalists
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
